FDA approves irinotecan as first-line therapy for colorectal cancer

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：652 / +
页数：2
相关论文
共 50 条
  • [21] Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer
    Masi, Gianluca
    Vasile, Enrico
    Loupakis, Fotios
    Bursi, Simona
    Ricci, Sergio
    Petrini, Iacopo
    Fontana, Andrea
    Allegrini, Giacomo
    Falcone, Alfredo
    CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 7 - 14
  • [22] Anti-EGFR therapy in first-line colorectal cancer
    Lamas, Maria J.
    Duran, Goretti
    Gallardo, Elena
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1499 - 1503
  • [23] Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer:: a phase II study
    Feliu, J
    Salud, A
    Escudero, P
    Lòpez-Gómez, L
    Pericay, C
    Castañón, C
    de Tejada, MRL
    Rodríguez-García, JM
    Martínez, MP
    Martín, MS
    Sánchez, JJ
    Barón, MG
    BRITISH JOURNAL OF CANCER, 2004, 90 (08) : 1502 - 1507
  • [24] Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer
    M. Méndez
    P. G. Alfonso
    E. Pujol
    E. González
    C. Castañon
    P. Cerezuela
    Y. López-Mateos
    J. J. Cruz
    Investigational New Drugs, 2005, 23 : 243 - 251
  • [25] Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
    Sadayuki Kawai
    Nozomi Takeshima
    Yu Hayasaka
    Akifumi Notsu
    Mutsumi Yamazaki
    Takanori Kawabata
    Kentaro Yamazaki
    Keita Mori
    Hirofumi Yasui
    BMC Cancer, 21
  • [26] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [27] Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment
    David J Kerr
    Nature Clinical Practice Oncology, 2008, 5 : 250 - 251
  • [28] Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
    Kawai, Sadayuki
    Takeshima, Nozomi
    Hayasaka, Yu
    Notsu, Akifumi
    Yamazaki, Mutsumi
    Kawabata, Takanori
    Yamazaki, Kentaro
    Mori, Keita
    Yasui, Hirofumi
    BMC CANCER, 2021, 21 (01)
  • [29] Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer
    Méndez, M
    Alfonso, PG
    Pujol, E
    González, E
    Castañon, C
    Cerezuela, P
    López-Mateos, Y
    Cruz, JJ
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 243 - 251
  • [30] Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer
    P García-Alfonso
    A J Muñoz-Martin
    S Alvarez-Suarez
    Y Jerez-Gilarranz
    M Riesco-Martinez
    P Khosravi
    M Martin
    British Journal of Cancer, 2010, 103 : 1524 - 1528
12345